For instance, in colorectal cancer, CircQSOX1 was found to activate glycolysis in colorectal cancer cells, fostering immune evasion and ultimately impeding the response to anti-CTLA-4 therapy in colorectal cancer patients [152]. This evidence concerns the gene CTLA4 and colorectal cancer.